No Data
No Data
Guangyuyuan Chinese Herbal Medicine Gets Government Grants Worth 13 Million Yuan
Guangyuyuan Chinese Herbal Medicine (SHA:600771) secured income-related government subsidies amounting to 12.8 million yuan, according to the company's disclosure published on the Shanghai Stock Excha
Guang Yuyuan (600771.SH): The subsidiary received a total of 12.7823 million yuan in government subsidies
Gelonghui, May 15, 丨 Guang Yuyuan (600771.SH) announced that since January 1, 2024, the company's relevant subsidiaries have received a total of 12.7823 million yuan in government subsidies related to revenue, accounting for 14.19% of the company's 2023 audited net profit attributable to shareholders of listed companies.
GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) Business Is Yet to Catch Up With Its Share Price
When you see that almost half of the companies in the Pharmaceuticals industry in China have price-to-sales ratios (or "P/S") below 3.4x, GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) lo
Guang Yuyuan (600771.SH) announced first-quarter results, net profit of 41.3036 million yuan, a year-on-year increase of 49.61%
Guang Yuyuan (600771.SH) released its report for the first quarter of 2024, with revenue of 343 million yuan, compared with...
Guang Yuyuan (600771.SH) and related personnel received the “Administrative Penalty Decision” and the “Market Ban Decision”
Zhitong Finance App News, Guang Yuyuan (600771.SH) announced that on April 10, 2024, the company and relevant parties received the “Administrative Penalty Decision” and “Market Ban Decision” issued by the Shanxi Regulatory Bureau (“Shanxi Securities Regulatory Bureau”) of the China Securities Regulatory Commission. It was discovered that the company and related parties had the following illegal facts: the disclosure of the “buyout sales” model in the company's 2016 to 2021 annual report was untrue. In the case where the subsidiary Shanxi Guangyuyuan Sinopharm Co., Ltd. (“Shanxi Guangyuyuan”) had an agreement with some downstream commercial companies that “the product is slow to sell and has an immediate expiration date, and can be returned unconditionally”
Zhang Bin, director of Guang Yuyuan (600771.SH), and Miao Hui, director and president, resign
Guang Yuyuan (600771.SH) issued an announcement. The board of directors of the company recently received Director Zhang Bin and Director and CEO Miao Hui...
No Data